<DOC>
	<DOCNO>NCT01721161</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy BIIB033 subject first episode unilateral acute optic neuritis ( AON ) . The secondary objective study ass safety , tolerability , pharmacokinetics ( PK ) BIIB033 study population .</brief_summary>
	<brief_title>BIIB033 In Acute Optic Neuritis ( AON )</brief_title>
	<detailed_description />
	<mesh_term>Optic Neuritis</mesh_term>
	<mesh_term>Neuritis</mesh_term>
	<criteria>Key Ability provide write consent authorization require law . Confirmed diagnosis AON All male female subject childbearing potential must practice effective contraception study willing able continue contraception least 6 month last dose study treatment . Key Prior episode ( ) optic neuritis loss vision due AON . Subjects establish diagnosis multiple sclerosis exclude except newly diagnose base current episode AON positive brain magnetic resonance imaging result consistent 2010 revision McDonald 's criterion . Previous history clinically significant disease . Females positive pregnancy test result , pregnant , breastfeeding , plan conceive study . History human immunodeficiency virus ( HIV ) , hepatitis C virus antibody , hepatitis B virus . History evidence drug alcohol abuse within 2 year prior Screening . Current enrollment study treatment disease study within 3 month prior Day 1/Baseline . NOTE : Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Optic Neuritis</keyword>
</DOC>